Literature DB >> 20235205

TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease.

Hua Xiao1, Han Lei, Shu Qin, Kanghua Ma, Xi Wang.   

Abstract

BACKGROUND: Atrial fibrosis was considered a structural basis for the development and sustaining of atrial fibrillation (AF). Transforming growth factor-beta1 (TGF-beta1) was one of the main factors for accelerating collagen production. The contribution of TGF-beta1 in the pathogenesis of AF needs further investigation. HYPOTHESIS: The altered expression and distribution of TGF-beta1 will be associated with the changes in atrial fibrosis in different types of AF patients with rheumatic heart disease (RHD).
METHODS: Right atrial specimens obtained from 38 RHD patients undergoing mitral valve replacement surgery were divided into 3 groups: the sinus rhythm group (n = 8), the paroxysmal AF group (pAF; n = 10), and the chronic AF group (cAF; AF lasting >/= 6 mo; n = 20). The degree of atrial fibrosis, collagen content, serum levels, messenger RNA (mRNA), and protein expression of TGF-beta1 were detected.
RESULTS: The collagen content, serum level, TGF-beta1 mRNA, and protein expression of the atrial tissue increased gradually in sinus rhythm, for both pAF and cAF groups, respectively. A positive correlation between TGF-beta1 and the degree of atrial fibrosis was also demonstrated (P < 0.05).
CONCLUSION: The TGF-beta1 expression in atrial tissue increased gradually in proportion to the degree of atrial fibrosis in AF and was associated with the type of AF, which suggests that TGF-beta1 is possibly involved in the pathogenesis of AF in RHD patients. Copyright (c) 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20235205      PMCID: PMC6652867          DOI: 10.1002/clc.20713

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  17 in total

1.  TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.

Authors:  Yu Sun; Zi-Yang Huang; Zhen-Hua Wang; Cui-Ping Li; Xian-Liang Meng; Yun-Jiao Zhang; Feng Su; Nan Ma
Journal:  Mol Cell Biochem       Date:  2015-05-14       Impact factor: 3.396

Review 2.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

Review 3.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

4.  Possible involvement of TGF-β/periostin in fibrosis of right atrial appendages in patients with atrial fibrillation.

Authors:  Han Wu; Jun Xie; Guan-Nan Li; Qin-Hua Chen; Ran Li; Xin-Lin Zhang; Li-Na Kang; Biao Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction.

Authors:  Xizhong Sui; Hongchao Wei; Dacheng Wang
Journal:  J Cell Mol Med       Date:  2015-03-30       Impact factor: 5.310

6.  Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts.

Authors:  Shao-lei Yi; Xiao-jun Liu; Jing-quan Zhong; Yun Zhang
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

7.  A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population.

Authors:  Hailong Cao; Qing Zhou; Rongfang Lan; Oluf Dimitri Røe; Xin Chen; Yijiang Chen; Dongjin Wang
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

8.  Angiotensin-converting enzyme-2 overexpression improves atrial remodeling and function in a canine model of atrial fibrillation.

Authors:  Tingquan Zhou; Zhenglong Wang; Jinqi Fan; Shaojie Chen; Zhen Tan; Hanxuan Yang; Yuehui Yin
Journal:  J Am Heart Assoc       Date:  2015-03-19       Impact factor: 5.501

9.  MG53/CAV1 regulates transforming growth factor-β1 signaling-induced atrial fibrosis in atrial fibrillation.

Authors:  Meixia Zhang; Hechuan Wang; Xiaowen Wang; Mengjun Bie; Kai Lu; Hua Xiao
Journal:  Cell Cycle       Date:  2020-10-01       Impact factor: 4.534

10.  Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease.

Authors:  Peide Zhang; Wei Wang; Xin Wang; Xu Wang; Yunhu Song; Yong Han; Jing Zhang; Hui Zhao
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.